OTC Watch

All stocks / OSRH

OSR Health, Inc. OSRH

OSR Health (OSRH): shares outstanding up 37% in a year, convertible notes mentioned in an 8-K in October 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

DilutionEstimated floatCostly financing Pink LimitedWashington, USA
Live quote on OTC Markets

Market listing

Full name
OSR HEALTH INC
Market tier
OTC Pink Limited
Trading status
Active
Last trade
Nov 16
Source: Stockwatch, 2026-11-17

News headlines

OSR Health Exercises $15 Million VXM01 Equity Option, Elects Settlement Through Staged Convertible Notes
2026-11-06 10:11 · News Release
OSR Health Board Authorizes Management to Engage with Potential Acquirer of OSRK for Reverse Takeover
2026-11-02 11:05 · News Release
OSR Health Provides Shareholder Update Following Nasdaq Panel Decision
2026-10-28 09:15 · News Release
Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc.
2026-08-27 17:02 · News Release
OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission
2026-08-21 11:46 · News Release
OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal
2026-08-19 15:45 · News Release
OSR Health Sees Global Shareholder Momentum at Critical Inflection Point
2026-08-19 06:30 · News Release
OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development
2026-08-11 08:53 · News Release
OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program
2026-08-07 15:00 · News Release
Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform
2026-08-03 09:02 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$2,905,805
Net loss
($27,058,541)
What it means

It spends more than it earns

Under strain

Customers paid it $2.9 million in the year. It lost $27.1 million. For every $1 that came in, about $10.31 went out.

The report says
Cash and cash equivalents
$1,700,273
Net cash used in operating activities
($4,328,034)
What it means

The cash could run out soon

Under strain

It had $1.7 million in the bank and used about $360,670 a month. At that pace the money lasts about 5 months unless it borrows or sells more shares.

The report says
Total assets
$171,238,248
Total liabilities
$44,200,845
What it means

It owns more than it owes

Steady

Everything the company owns adds up to $171.2 million. Its debts and unpaid bills add up to $44.2 million. That is about $0.26 owed for every $1 owned.

What this adds up to

2 of 3 checks show strain. It spends more than it earns. The cash could run out soon. These are facts from the company's own reports, not a recommendation.

Signals

Dilution2026-11-13

Shares outstanding rose from 25,672,788 (2025-11-05) to 35,258,692 (2026-11-13), up 37%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-11-13

Estimated float about 35,258,692 shares as of 2026-11-13: 35,258,692 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Costly financing2026-10-16

8-K filed 2026-10-16 mentions: convertible note.

Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record

Shares outstanding

Source: SEC filings
2025-11-05
25.7M
2025-12-31
26.6M
2026-03-20
33.1M
2026-03-31
33.3M
2026-05-10
35.1M
2026-06-30
35.1M
2026-08-10
35.1M
2026-11-13
35.3M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-13 8-KCURRENT REPORT
2026-11-13 10-QQUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2026
2026-10-28 8-KCURRENT REPORT
2026-10-16 8-KCURRENT REPORT
2026-10-02 8-KCURRENT REPORT
2026-08-28 8-KCURRENT REPORT
2026-08-25 8-KCURRENT REPORT
2026-08-19 8-KCURRENT REPORT
2026-08-17 SCHEDULE 13G/A
2026-08-14 10-QQUARTERLY REPORT
2026-08-10 8-KCURRENT REPORT
2026-08-07 8-KCURRENT REPORT

Common questions about OSRH

Does OSRH file reports with the SEC?

Yes. OSR Health files with the SEC under company number 0001840425. The most recent filing we hold is a 8-K dated 2026-11-13.

Source record

How many OSRH shares are outstanding?

35,258,692 shares as of 2026-11-13, as reported to the SEC. That is up 37% from 25,672,788 on 2025-11-05.

Source record

Has OSRH filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Who runs OSR Health?

Officers named in its insider filings: Yeiseok Kim (Chief Operating Officer).

Source record

Is OSR Health making money?

Customers paid it $2.9 million in the year. It lost $27.1 million. For every $1 that came in, about $10.31 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record